Characteristics | Total N = 2507 | Late presenters (%) | Unadjusted OR (CI) | p value | Adjusted OR (CI) | p value |
---|---|---|---|---|---|---|
Sex | ||||||
Male | 2097 | 1153 (55.0) | 1 | 0.18 | ||
Female | 410 | 240 (58.5) | 1.16 (0.93-1.44) | |||
Age at HIV diagnosis* | ||||||
All | 35.4 (29.6-42.8) | 37.9 (31.5-46.2) | 0.0001 | 1.38 (1.27-1.40) | <0.0001 | |
Male | 35.4 (29.7-42.5) | 38.0 (31.8-45.8) | ||||
Female | 35.3 (29.4-44.4) | 37.7 (30.6-47.2) | ||||
Age (per a 5 yrs increase) | ||||||
Region of birth | ||||||
Spain | 1460 | 826 (56.6) | 1 | 0.002 | 1 | 0.279 |
Western Europe & North America | 166 | 73 (44.0) | 0.60 (0.43-0.84) | 0.2 | 0.83 (0.59-1.16) | < 0.0001 |
Latin America & Caribbean | 570 | 315 (55.3) | 0.95 (0.78-1.16) | 0.8 | 1.48 (1.20-1.83) | 0.838 |
Middle East & North Africa | 44 | 26 (59.1) | 1.11 (0.58-2.13) | 0.02 | 1.07 (0.56-2.03) | 0.002 |
Sub-Saharan Africa | 74 | 52 (70.3) | 1.81 (1.08-3.12) | 0.9 | 2.43 (1.14-4.17) | 0.274 |
Eastern Europe | 64 | 36 (56.3) | 0.99 (0.58-1.68) | 0.2 | 1.35 (0.79-2.31) | 0.219 |
Asia | 18 | 13 (72.2) | 2.00 (0.66-6.44) | 0.05 | 1.96 (0.67-5.74) | 0.107 |
unknown | 111 | 52 (46.8) | 0.68 (0.45-1.01) | 0.71 (0.47-1.07) | ||
Exposure category** | ||||||
MSM | 1333 | 636 (47.7) | 1 | < 0.001 | 1 | < 0.0001 |
IDU men | 252 | 166 (65.9) | 2.12 (1.58-2.83) | < 0.001 | 2.12 (1.57-2.87) | < 0.0001 |
HT men | 382 | 269 (70.4) | 2.61 (2.03-3.36) | 0.9 | 1.79 (1.38-2.34) | 0.340 |
IDU women | 62 | 34 (54.8) | 1.33 (0.78-2.29) | 0.004 | 1.29 (0.76-2.20) | 0.279 |
HT women | 319 | 181 (56.7) | 1.44 (1.12-1.85) | < 0.001 | 1.16 (0.88-1.51) | 0.009 |
unknown | 159 | 107 (67.3) | 2.26 (1.57-3.24) | 1.63 (1.13-2.37) | ||
Year of diagnosis | ||||||
2001-2003 | 805 | 505 (62.7) | 1 | < 0.001 | 1 | 0.001 |
2004-2005 | 538 | 279 (51.2) | 0.64 (0.51-0.80) | < 0.001 | 0.67 (0.53-0.85) | 0.001 |
2006-2007 | 607 | 319 (52.6) | 0.66 (0.53-0.82) | < 0.001 | 0.67 (0.53-0.85) | 0.001 |
2008-2009 | 557 | 290 (52.1) | 0.65 (0.52-0.81) | 0.71 (0.56-0.90) |